Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT).
Spotlight
November 6, 2017 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS Read More
November 6, 2017 Flex Pharma Reports Third Quarter 2017 Financial Results Read More
